Cargando…
A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening
Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152369/ https://www.ncbi.nlm.nih.gov/pubmed/21602263 http://dx.doi.org/10.1093/nar/gkr382 |
_version_ | 1782209764076290048 |
---|---|
author | Rakauskaitė, Rasa Liao, Pei-Yu Rhodin, Michael H. J. Lee, Kelvin Dinman, Jonathan D. |
author_facet | Rakauskaitė, Rasa Liao, Pei-Yu Rhodin, Michael H. J. Lee, Kelvin Dinman, Jonathan D. |
author_sort | Rakauskaitė, Rasa |
collection | PubMed |
description | Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae, to deliver the correct ratios of different viral proteins for efficient replication. Thus, −1 PRF presents a novel target for antiviral therapeutics. The underlying molecular mechanism of −1 PRF is conserved from yeast to mammals, enabling yeast to be used as a logical platform for high-throughput screens. Our understanding of the strengths and pitfalls of assays to monitor −1 PRF have evolved since the initial discovery of −1 PRF. These include controlling for the effects of drugs on protein expression and mRNA stability, as well as minimizing costs and the requirement for multiple processing steps. Here we describe the development of an automated yeast-based dual fluorescence assay of −1 PRF that provides a rapid, inexpensive automated pipeline to screen for compounds that alter rates of −1 PRF which will help to pave the way toward the discovery and development of novel antiviral therapeutics. |
format | Online Article Text |
id | pubmed-3152369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31523692011-08-08 A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening Rakauskaitė, Rasa Liao, Pei-Yu Rhodin, Michael H. J. Lee, Kelvin Dinman, Jonathan D. Nucleic Acids Res Methods Online Programmed −1 ribosomal frameshifting (−1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5′ direction that is utilized by many RNA viruses. Importantly, rates of −1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae, to deliver the correct ratios of different viral proteins for efficient replication. Thus, −1 PRF presents a novel target for antiviral therapeutics. The underlying molecular mechanism of −1 PRF is conserved from yeast to mammals, enabling yeast to be used as a logical platform for high-throughput screens. Our understanding of the strengths and pitfalls of assays to monitor −1 PRF have evolved since the initial discovery of −1 PRF. These include controlling for the effects of drugs on protein expression and mRNA stability, as well as minimizing costs and the requirement for multiple processing steps. Here we describe the development of an automated yeast-based dual fluorescence assay of −1 PRF that provides a rapid, inexpensive automated pipeline to screen for compounds that alter rates of −1 PRF which will help to pave the way toward the discovery and development of novel antiviral therapeutics. Oxford University Press 2011-08 2011-05-20 /pmc/articles/PMC3152369/ /pubmed/21602263 http://dx.doi.org/10.1093/nar/gkr382 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methods Online Rakauskaitė, Rasa Liao, Pei-Yu Rhodin, Michael H. J. Lee, Kelvin Dinman, Jonathan D. A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title | A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title_full | A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title_fullStr | A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title_full_unstemmed | A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title_short | A rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
title_sort | rapid, inexpensive yeast-based dual-fluorescence assay of programmed—1 ribosomal frameshifting for high-throughput screening |
topic | Methods Online |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152369/ https://www.ncbi.nlm.nih.gov/pubmed/21602263 http://dx.doi.org/10.1093/nar/gkr382 |
work_keys_str_mv | AT rakauskaiterasa arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT liaopeiyu arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT rhodinmichaelhj arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT leekelvin arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT dinmanjonathand arapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT rakauskaiterasa rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT liaopeiyu rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT rhodinmichaelhj rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT leekelvin rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening AT dinmanjonathand rapidinexpensiveyeastbaseddualfluorescenceassayofprogrammed1ribosomalframeshiftingforhighthroughputscreening |